Medications
belantamab mafodotin
Antibody-Drug Conjugates
Approved use in
Multiple Myeloma
Bortezomib (Velcade)
Proteasome Inhibitors
Approved use in
Multiple Myeloma
carfilzomib
Proteasome Inhibitors
Approved use in
Multiple Myeloma
Ciltacabtagene autoleucel (Carvykti)
CAR T-Cell Therapy
Approved use in
Multiple Myeloma
daratumumab
Monoclonal Antibodies
Approved use in
Multiple Myeloma
dexamethasone
Systemic Steroids
Approved use in
Multiple Myeloma
doxorubicin
Chemotherapy Agents
Approved use in
Multiple Myeloma
elotuzumab
Monoclonal Antibodies
Approved use in
Multiple Myeloma
Elranatamab
Bispecific Antibodies
Approved use in
Multiple Myeloma
ibrutinib
Tyrosine Kinase Inhibitors
Approved use in
Multiple Myeloma
Idecabtagene Vicleucel
CAR T-Cell Therapy
Approved use in
Multiple Myeloma
isatuximab
Monoclonal Antibodies
Approved use in
Multiple Myeloma
ixazomib
Proteasome Inhibitors
Approved use in
Multiple Myeloma
lenalidomide
Immunomodulatory Agents
Approved use in
Multiple Myeloma
nivolumab
Monoclonal Antibodies
Approved use in
Multiple Myeloma
Pembrolizumab (Keytruda)
Immune Therapies
Approved use in
Multiple Myeloma
pomalidomide
Immunomodulatory Agents
Approved use in
Multiple Myeloma
rituximab
Monoclonal Antibodies
Approved use in
Multiple Myeloma
selinexor
Selective Inhibitor of Nuclear Export
Approved use in
Multiple Myeloma
talquetamab
Bispecific Antibodies
Approved use in
Multiple Myeloma
teclistamab
Bispecific Antibodies
Approved use in
Multiple Myeloma
thalidomide
Immunomodulatory Agents
Approved use in
Multiple Myeloma
venetoclax
Targeted Therapies
Approved use in
Multiple Myeloma